Clinical study for moderate sedation with low dose propofol combined with sufentanil at BIS's direction in gastroscopy of patients with snoring

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR1900024894

Enrollment

Unknown

Registered

2019-08-02

Start date

2019-08-03

Completion date

Unknown

Last updated

2019-08-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Sleep apnea

Interventions

S group:Moderate sedation with low dose propofol combined with sufentanil

Control group:Slow intravenous injection of propofol 1.5-2.5 mg/kg until the patient holds a 20 ml syringe and drops off

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Aged 18-70 years; 2. Grade 1-3 snoring (grade 0: never snore; Level 1: breathing sound is heavier than normal people; Level 2: snoring is louder than ordinary people; Level 3: unable to sleep; Level 4: intermittent sleep breathing).

Exclusion criteria

Exclusion criteria: 1. Patients with delayed waking at night or severe snoring who had been diagnosed with obstructive sleep apnea syndrome (OSAS); 2. Severe cardiovascular and cerebrovascular diseases, heart block disease, liver and kidney dysfunction and neuropsychiatric diseases; 3. Pregnancy, lactation or preparation for a recent pregnancy; 4. Allergic to propofol or opioids; 5. Contraindications to painless gastroscopy or surgery may affect patient safety during the study; With serious cardiovascular and cerebrovascular diseases, heart block diseases, liver and kidney dysfunction or neuropsychiatric diseases; With pain - free gastroscopy anesthesia or surgical contraindications.

Design outcomes

Primary

Measure	Time frame
Spo2;body movement;HR;MAP;	—

Countries

China

Contacts

Public ContactKang Shuai

The Second Affiliated Hospital, Jiaxing College

15024340122@163.com+86 15024340122

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026